|
(Health-NewsWire.Net, October 15, 2021 )
Market Overview
Hematology tests examine the blood, blood proteins, and organs that produce blood. Infection, anemia, inflammation, hemophilia, blood-clotting problems, leukemia, and the body's response to chemotherapy treatments are all illnesses that can be evaluated with these tests.
View full report: https://www.datamintelligence.com/research-report/hematology-testing-products-market
Market Dynamics
The factors driving the market growth of the hematology testing products market are the technological advancements in the hematology analyzer and the increasing number of patients opting for blood tests.
Technological advancements in the hematology analyzer is expected to drive market growth in the forecast period
Hematology analyzers employ a variety of technologies to identify cell types in a blood sample and count them separately in order to provide a complete blood count (CBC) with differential.
Internal cellular particles are stained with a fluorescent dye and the emitted light is captured, enzymatic properties of cells such as the presence of myeloperoxidase are used, and cellular volume is measured using direct current impedance (Coulter Principle).
To separate cellular elements, some analyzers only have one histogram per module; however, modern analyzers can retrieve data from many histograms. This is achievable in analyzers that contain modern VCSn technology, which can collect multiple additional cellular metrics for each individual cell, including but not limited to five various angles of light scatter and pulse time, in addition to volume and conductivity.
This data can be combined in a variety of ways to generate dozens of histograms per module, allowing distinct cellular constituents to be distinguished.
The VCS technology was primarily employed to generate the differential count in hematological analyzers that did not have this technology. The enhanced VCSn data is used across all analytical modules in newer analyzers, including the differential, reticulocyte, and nRBC modules, allowing the instrument to leverage this powerful technology to improve counting and detect many more important cellular elements, as well as provide an accurate and precise CBC-diff. Today's technical advancements in hematology analyzers provide the laboratory with more cellular information than was previously available through a basic routine CBC with differential. This new information can be used to improve cellular counting and reduce the number of manual checks that are unnecessary.
For example, On February 1st, 2021, Beckman Coulter launched, the DxH 560 AL which is a tabletop hematology analyzer developed to decrease the time and resource restrictions faced by small- to mid-sized laboratories. The DxH 560 AL produces results in less than 60 seconds. Because it only requires a 17-liter sample (less than a drop of blood), it can be utilized with difficult-to-draw patients (infants, cancer, and the elderly).
Market Segmentation
Global Hematology Testing Products Market - By Product Type
Instruments
Consumables
Global Hematology Testing Products Market - By Type of Tests
Complete Blood Count Analysis
White Blood Cell Analysis
Hemoglobin Test
Bone Marrow Analysis
Others
Global Hematology Testing Products Market - By End-User
Hospitals
Diagnostic Centers
Research laboratories
Global Hematology Testing Products Market - By Region
North America
Europe
South America
Asia Pacific
Middle East and Africa
Download free sample:https://www.datamintelligence.com/download-sample/hematology-testing-products-market
Competitive Landscape
The global hematology testing products market is highly competitive with the rising number of diseases and technological advancement in diagnostics.
Some of the major key players in this market are Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Boule Diagnostics AB, Horiba, Ltd., Mindray Medical International Limited, Siemens Healthcare, Sysmex Corporation, Abbott Corelaboratory, Agappe Diagnostics and Bioway Biological Technology Co.,Ltd.
Bio-Rad Laboratories
Overview: Bio-Rad is a global leader in the development, manufacture, and marketing of cutting-edge products for life science research and clinical diagnostics. Their products promote the discovery process and improve healthcare by focusing on quality and customer service for over 65 years.
University and research institutions, hospitals, public health, and commercial laboratories, biotechnology, and pharmaceutical laboratories, as well as applied laboratories such as food safety and environmental quality, are among their customers.
Topic's you may be interested, Hematocrit Test Devices Market, Embolotherapy Market, Haemodialysis Equipment Market, Pregnancy and Fertility Testing Products Market, Cardiometabolic Monitoring Products Market
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
|
